Home »
INDIANAPOLIS, Feb. 10, 2020 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) today announced that the analysis performed by Washington University School of Medicine in the Dominantly Inherited Alzheimer Network […] EAST HANOVER, N.J., Feb. 11, 2020 /PRNewswire/ — Novartis announced today that the US Food and Drug Administration (FDA) accepted and granted Priority Review to capmatinib’s (INC280) […] Generic prescription drugs have saved the U.S. about US$1.7 trillion over the past decade. The Food and Drug Administration approved a record 781 new generics […] About 10% of the world population suffers from migraine headaches, according to the National Institute of Neurological Disorders and Stroke. To alleviate migraine pain, people […] Researchers at the University of Alberta have discovered a new class of drugs with the potential to make cancer treatment safer and more effective by […] (HealthDay)—A cheap drug that’s been around for centuries as a gout treatment might also shield heart attack survivors from future heart crises, new trial results […] Survival for patients with the most common forms of advanced breast cancer could be substantially improved if both younger and older patients had access to […] Patients receiving checkpoint inhibitor therapy often have acute kidney injury (AKI), according to a study published online Oct. 31 in the Clinical Journal of the […] Prescriptions for drugs to treat anxiety, alcohol withdrawal and sleep problems are highest in the most deprived areas in England, according to a new study […] A test to detect opioid drugs in exhaled breath has been developed by engineers and physicians at the University of California, Davis. A breath test […] In a new register-based study, Swedish and Danish researchers show that common drugs for Inflammatory Bowel Disease (IBD), so called TNF-α inhibitors, are not linked […] (HealthDay)—A new drug has been approved as part of a powerful, three-pronged treatment regimen for the most deadly strain of tuberculosis, the U.S. Food and […] Stomach-protecting drugs are widely used. Now, using quantitative prescribing data from Austria, a study conducted by MedUni Vienna in collaboration with the Austrian Social Insurance […] (HealthDay)—Metformin use is associated with a substantially lower risk for dementia among younger African-American patients with diabetes compared with sulfonylurea initiation, according to a study […] As American policymakers and health care providers try multiple approaches to reduce the number of deaths related to the opioid epidemic, treatment facilities are commonly […] (HealthDay)—The addition of bevacizumab to carboplatin/pemetrexed is associated with improved overall survival among patients with advanced non-small cell lung cancer (NSCLC), according to a study […] Buprenorphine-naloxone (buprenorphine), a highly effective, evidence-based treatment for opioid use disorder (OUD), is difficult to access in states with high rates of death associated with […] CBD, or cannabidiol, is everywhere, with word on the street saying that it can cure everything from a bad mood to cancer. However, most of […]
Lilly Announces Topline Results for Solanezumab from the Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU) Study
Novartis Announces MET Inhibitor Capmatinib (INC280), the First Potential Treatment for METex14 Mutated Advanced Non-Small Cell Lung Cancer, Granted Priority FDA Review
Why your generic drugs may not be safe and the FDA may be too lax
A new link between migraines, opioid overuse may be key to treating pain
Scientists discover new drugs with potential to treat stubborn cancers
Cheap, older gout drug could be a lifesaver after heart attack
Advanced breast cancer patients denied access to life-prolonging drugs and opioids
Acute kidney injury often seen with checkpoint inhibitor use
Prescribing rates for anxiety and sleeping drugs highest in deprived areas
A breath test for opioids
Study rejects link between common IBD drug and serious infections in children
FDA approves drug for most deadly form of tuberculosis
Stomach-protecting medicines can trigger allergies
Metformin may lower dementia risk in black patients with T2DM
40% of treatment facilities won’t accept people prescribed meds to fight opioid addiction
Adding bevacizumab improves overall survival in NSCLC
Significant barriers to care for patients seeking medication for opioid use
CBD: The next weapon in the war against opioid addiction?
Copyright © 2020